Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q2 2025 Earnings

14MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.66

-0.61

-0.56

-0.51

Details

Expected EPS

-0.6425

Actual EPS

-0.51

Surprise EPS

0.13

Surprise Percent

+20.62%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.51 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.